Cargando…
The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review
Ketamine, a non-competitive N-methyl-d-aspartate receptor antagonist, is commonly used as an anesthetic and analgesic but has recently shown promising research in treating certain psychiatric conditions such as depression, post-traumatic stress disorder (PTSD), suicidal ideation, and substance use d...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053551/ https://www.ncbi.nlm.nih.gov/pubmed/35505747 http://dx.doi.org/10.7759/cureus.23647 |
_version_ | 1784697005115703296 |
---|---|
author | Sepulveda Ramos, Carolina Thornburg, Matthew Long, Kelly Sharma, Kiran Roth, Julia Lacatusu, Diana Whitaker, Reece Pacciulli, Daniel Moredo Loo, Sulma Manzoor, Mohammad Tsang, Yun-Yee Molenaar, Sydney Sundar, Karthikeyan Jacobs, Robin J |
author_facet | Sepulveda Ramos, Carolina Thornburg, Matthew Long, Kelly Sharma, Kiran Roth, Julia Lacatusu, Diana Whitaker, Reece Pacciulli, Daniel Moredo Loo, Sulma Manzoor, Mohammad Tsang, Yun-Yee Molenaar, Sydney Sundar, Karthikeyan Jacobs, Robin J |
author_sort | Sepulveda Ramos, Carolina |
collection | PubMed |
description | Ketamine, a non-competitive N-methyl-d-aspartate receptor antagonist, is commonly used as an anesthetic and analgesic but has recently shown promising research in treating certain psychiatric conditions such as depression, post-traumatic stress disorder (PTSD), suicidal ideation, and substance use disorder. Due to its euphoric, dissociative, and hallucinogenic properties, ketamine has been abused as a recreational drug, which has led to rigid regulation of medication. The COVID-19 pandemic has been an unprecedented challenge for the American population which was reflected in increased reports of problems regarding their mental health. Mood disorders have dramatically increased in the past two years. Approximately one in ten people stated that they had started or increased substance use because of the COVID-19 pandemic. Furthermore, rates of suicidal ideation have significantly increased when compared to pre-pandemic levels, with more than twice the number of adults surveyed in 2018 indicating suicidal thoughts “within the last 30 days” at the time they were surveyed. Moreover, many responders indicated they had symptoms of PTSD. The PubMed database was searched using the keyword “ketamine,” in conjunction with “depression,” “suicidal ideation,” “substance use disorder,” and “post-traumatic stress disorder.” The inclusion criteria encompassed articles from 2017 to 2022 published in the English language that addressed the relationship between ketamine and mental health disorders. With this sharp increase in the prevalence of psychiatric disorders and an increased public interest in mental health combined with the promise of the therapeutic value of ketamine for certain mental health conditions, including suicidal ideation, this narrative review sought to identify recently published studies that describe the therapeutic uses of ketamine for mental health. Results of this review indicate that ketamine’s therapeutic effects offer a potential alternative treatment for depression, suicidal ideation, substance use disorders, and PTSD. |
format | Online Article Text |
id | pubmed-9053551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-90535512022-05-02 The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review Sepulveda Ramos, Carolina Thornburg, Matthew Long, Kelly Sharma, Kiran Roth, Julia Lacatusu, Diana Whitaker, Reece Pacciulli, Daniel Moredo Loo, Sulma Manzoor, Mohammad Tsang, Yun-Yee Molenaar, Sydney Sundar, Karthikeyan Jacobs, Robin J Cureus Psychiatry Ketamine, a non-competitive N-methyl-d-aspartate receptor antagonist, is commonly used as an anesthetic and analgesic but has recently shown promising research in treating certain psychiatric conditions such as depression, post-traumatic stress disorder (PTSD), suicidal ideation, and substance use disorder. Due to its euphoric, dissociative, and hallucinogenic properties, ketamine has been abused as a recreational drug, which has led to rigid regulation of medication. The COVID-19 pandemic has been an unprecedented challenge for the American population which was reflected in increased reports of problems regarding their mental health. Mood disorders have dramatically increased in the past two years. Approximately one in ten people stated that they had started or increased substance use because of the COVID-19 pandemic. Furthermore, rates of suicidal ideation have significantly increased when compared to pre-pandemic levels, with more than twice the number of adults surveyed in 2018 indicating suicidal thoughts “within the last 30 days” at the time they were surveyed. Moreover, many responders indicated they had symptoms of PTSD. The PubMed database was searched using the keyword “ketamine,” in conjunction with “depression,” “suicidal ideation,” “substance use disorder,” and “post-traumatic stress disorder.” The inclusion criteria encompassed articles from 2017 to 2022 published in the English language that addressed the relationship between ketamine and mental health disorders. With this sharp increase in the prevalence of psychiatric disorders and an increased public interest in mental health combined with the promise of the therapeutic value of ketamine for certain mental health conditions, including suicidal ideation, this narrative review sought to identify recently published studies that describe the therapeutic uses of ketamine for mental health. Results of this review indicate that ketamine’s therapeutic effects offer a potential alternative treatment for depression, suicidal ideation, substance use disorders, and PTSD. Cureus 2022-03-30 /pmc/articles/PMC9053551/ /pubmed/35505747 http://dx.doi.org/10.7759/cureus.23647 Text en Copyright © 2022, Sepulveda Ramos et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Psychiatry Sepulveda Ramos, Carolina Thornburg, Matthew Long, Kelly Sharma, Kiran Roth, Julia Lacatusu, Diana Whitaker, Reece Pacciulli, Daniel Moredo Loo, Sulma Manzoor, Mohammad Tsang, Yun-Yee Molenaar, Sydney Sundar, Karthikeyan Jacobs, Robin J The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review |
title | The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review |
title_full | The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review |
title_fullStr | The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review |
title_full_unstemmed | The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review |
title_short | The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review |
title_sort | therapeutic effects of ketamine in mental health disorders: a narrative review |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053551/ https://www.ncbi.nlm.nih.gov/pubmed/35505747 http://dx.doi.org/10.7759/cureus.23647 |
work_keys_str_mv | AT sepulvedaramoscarolina thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT thornburgmatthew thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT longkelly thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT sharmakiran thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT rothjulia thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT lacatusudiana thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT whitakerreece thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT pacciullidaniel thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT moredoloosulma thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT manzoormohammad thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT tsangyunyee thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT molenaarsydney thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT sundarkarthikeyan thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT jacobsrobinj thetherapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT sepulvedaramoscarolina therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT thornburgmatthew therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT longkelly therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT sharmakiran therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT rothjulia therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT lacatusudiana therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT whitakerreece therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT pacciullidaniel therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT moredoloosulma therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT manzoormohammad therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT tsangyunyee therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT molenaarsydney therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT sundarkarthikeyan therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview AT jacobsrobinj therapeuticeffectsofketamineinmentalhealthdisordersanarrativereview |